Use the Back button in your browser to see the other results of your search or to select another record.
A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy versus etretinate (re-TL-01) versus etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients |
Green C, Lakshmipathi T, Johnson BE, Ferguson J |
British Journal of Dermatology 1992 Jul;127(1):5-9 |
clinical trial |
4/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: No; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|